NCT03135197View on ClinicalTrials.gov

German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.

CompletedOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions

Fabry Disease

Trial Locations (1)

48149

Universtiy Hospital Münster, Münster

Sponsors

Collaborators (1)

Amicus Therapeutics

All Listed Sponsors

collaborator

Amicus Therapeutics

INDUSTRY

lead

University Hospital Muenster

OTHER